✦ LIBER ✦

Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis

✍ Scribed by Dagmar Berghuis; Marco W Schilham; Hanneke I Vos; Susy J Santos; Stephan Kloess; Emilie P Buddingh’; R Maarten Egeler; Pancras CW Hogendoorn; Arjan C Lankester

Book ID: 115028015
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 583 KB
Volume: 2
Category: Article
ISSN: 2045-3329
DOI: 10.1186/2045-3329-2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-γ down-regulates NKG2D ligand

Interferon-γ down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells

✍ Nicole Schwinn; Daria Vokhminova; Antje Sucker; Sonja Textor; Sandra Striegel; I 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 985 KB

## Abstract NKG2D operates as an activating receptor on natural killer (NK) cells and costimulates the effector function of αβ CD8^+^ T cells. Ligands of NKG2D, the MHC class I chain‐related (MIC) and UL16 binding protein (ULBP) molecules, are expressed on a variety of human tumors, including melan

Enhanced In Vitro Expression Of NKG2D Li

Enhanced In Vitro Expression Of NKG2D Ligands MIC A And MIC B With Histone Deacetylase Inhibitor (HDACi) Romidepsin In Pediatric Leukemia And Lymphomas: Potential for Natural Killer Cell Mediated Targeted Adoptive Cellular Immunotherapy (ACI)

✍ P. Satwani; A. Saha; S. Bavishi; L. Segal; M.S. Cairo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Differentiation-promoting drugs up-regul

Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis

✍ Andreas Rohner; Ulrich Langenkamp; Uwe Siegler; Christian P. Kalberer; Aleksandr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 842 KB

Up-regulation of NKG2D ligands by AML ce

Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: The tumour might strike back: Comment on “Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis” by Rohner et al. [Leuk Res 2007;31:1393–402]

✍ Jacques Zimmer; Tatiana Michel; Emmanuel Andrès; François Hentges 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB